Fund Holdings — DIADEMA PARTNERS LP

Total Portfolio Value:
$167.91M
Total Bought:
$111.57M
Total Sold:
$87.45M
Net Transaction:
+$24.12M
Notable People:
Timothy Beau Bassett
Securities
▲▼
SharesValue
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Terns Pharmaceuticals Inc323,159345,880+22,721$2.43M$13.97M8.32%+$11.55M
Johnson & Johnson(JNJ)066,444+66,444$0$13.75M8.19%+$13.75M
Viking Therapeutics, Inc.(VKTX)193,689336,849+143,160$5.09M$11.85M7.06%+$6.76M
ABIVAX Société AnonymeADS(ABVX)41,62075,644+34,024$3.51M$10.20M6.08%+$6.69M
BioMarin Pharmaceutical Inc.(BMRN)212,877146,361-66,516$11.53M$8.70M5.18%-$2.83M
Regeneron Pharmaceuticals, Inc.(REGN)30,16010,300-19,860$16.96M$7.95M4.73%-$9.01M
BridgeBio Pharma, Inc.(BBIO)070,000+70,000$0$5.35M3.19%+$5.35M
United Therapeutics Corporation(UTHR)010,000+10,000$0$4.87M2.90%+$4.87M
Cogent Biosciences, Inc.(COGT)97,813131,852+34,039$1.40M$4.68M2.79%+$3.28M
Capricor Therapeutics, Inc.(CAPR)0158,075+158,075$0$4.56M2.72%+$4.56M
Vertex Pharmaceuticals Incorporated(VRTX)010,000+10,000$0$4.53M2.70%+$4.53M
ANI Pharmaceuticals, Inc.(ANIP)31,40053,354+21,954$2.88M$4.21M2.51%+$1.34M
TG Therapeutics, Inc.(TGTX)60,748123,283+62,535$2.19M$3.68M2.19%+$1.48M
BioAge Labs, Inc.(BIOA)0271,164+271,164$0$3.59M2.14%+$3.59M
Corcept Therapeutics Incorporated(CORT)097,445+97,445$0$3.39M2.02%+$3.39M
Tenax Therapeutics, Inc.(TENX)0243,170+243,170$0$2.96M1.77%+$2.96M
Revolution Medicines, Inc.(RVMD)59,07937,020-22,059$2.76M$2.95M1.76%+$189.7K
Immunocore Holdings plcADS(IMCR)124,38470,300-54,084$4.52M$2.44M1.45%-$2.08M
Ironwood Pharmaceuticals, Inc.CL A(IRWD)0683,611+683,611$0$2.30M1.37%+$2.30M
Centessa Pharmaceuticals PlcADS090,000+90,000$0$2.25M1.34%+$2.25M
Replimune Group, Inc.(REPL)0230,997+230,997$0$2.25M1.34%+$2.25M
Eli Lilly and Company(LLY)02,000+2,000$0$2.15M1.28%+$2.15M
Alnylam Pharmaceuticals, Inc.(ALNY)10,0005,341-4,659$4.56M$2.12M1.26%-$2.44M
Lipocine Inc.(LPCN)0260,939+260,939$0$2.10M1.25%+$2.10M
Protagonist Therapeutics Inc51,18522,700-28,485$3.40M$1.98M1.18%-$1.42M
Relmada Therapeutics, Inc.(RLMD)0389,395+389,395$0$1.88M1.12%+$1.88M
Ventyx Biosciences Inc71,204200,000+128,796$221.4K$1.81M1.08%+$1.58M
Annexon, Inc.(ANNX)0350,000+350,000$0$1.76M1.05%+$1.76M
MannKind Corporation(MNKD)212,475302,000+89,525$1.14M$1.71M1.02%+$571.3K
Inventiva S.A.ADS(IVA)0334,251+334,251$0$1.55M0.93%+$1.55M
BioCryst Pharmaceuticals, Inc.(BCRX)0190,928+190,928$0$1.49M0.89%+$1.49M
Ardelyx Inc400,000252,198-147,802$2.20M$1.47M0.88%-$733.7K
Ascendis Pharma A/SADR(ASND)27,5726,840-20,732$5.48M$1.46M0.87%-$4.02M
Xeris Biopharma Holdings Inc74,753170,568+95,815$608.5K$1.34M0.80%+$730.5K
Rigel Pharmaceuticals, Inc.(RIGL)030,000+30,000$0$1.28M0.77%+$1.28M
Soleno Therapeutics Inc177,33026,892-150,438$11.99M$1.25M0.74%-$10.74M
Pacira BioSciences, Inc.(PCRX)58,92648,025-10,901$1.52M$1.24M0.74%-$275.6K
Trevi Therapeutics, Inc.(TRVI)85,83097,184+11,354$785.3K$1.22M0.72%+$431.4K
MapLight Therapeutics, Inc.(MPLT)063,791+63,791$0$1.12M0.67%+$1.12M
uniQure N.V.SHS(QURE)045,000+45,000$0$1.08M0.64%+$1.08M
Vaxcyte, Inc.(PCVX)218,28522,972-195,313$7.86M$1.06M0.63%-$6.80M
Enanta Pharmaceuticals, Inc.(ENTA)065,138+65,138$0$1.03M0.61%+$1.03M
Prothena Corp PlcSHS
SHS
0106,539+106,539$0$1.02M0.61%+$1.02M
Monte Rosa Therapeutics, Inc.(GLUE)062,281+62,281$0$976.6K0.58%+$976.6K
Design Therapeutics, Inc.(DSGN)0100,320+100,320$0$941.0K0.56%+$941.0K
Inovio Pharmaceuticals, Inc.(INO)0533,682+533,682$0$928.6K0.55%+$928.6K
Mineralys Therapeutics, Inc.(MLYS)025,000+25,000$0$907.3K0.54%+$907.3K
Aytu Biopharma Inc272,670305,788+33,118$512.6K$795.0K0.47%+$282.4K
Pelthos Therapeutics Inc.(PTHS)10,49825,000+14,502$293.9K$775.0K0.46%+$481.1K
Liquidia Corporation(LQDA)021,881+21,881$0$754.7K0.45%+$754.7K
Edgewise Therapeutics, Inc.(EWTX)030,000+30,000$0$744.5K0.44%+$744.5K
Viridian Therapeutics, Inc.(VRDN)021,114+21,114$0$657.1K0.39%+$657.1K
Indivior Plc254,25217,320-236,932$6.13M$621.4K0.37%-$5.51M
Vir Biotechnology, Inc.(VIR)0100,000+100,000$0$603.0K0.36%+$603.0K
Ligand Pharmaceuticals Incorporated(LGND)02,987+2,987$0$564.8K0.34%+$564.8K
Upstream Bio, Inc.(UPB)020,500+20,500$0$556.6K0.33%+$556.6K
Stoke Therapeutics, Inc.(STOK)017,181+17,181$0$545.3K0.32%+$545.3K
Equillium, Inc.(EQ)300,000347,393+47,393$429.0K$538.5K0.32%+$109.5K
UroGen Pharma Ltd.(URGN)90,00021,810-68,190$1.80M$510.8K0.30%-$1.28M
Immunome, Inc.(IMNM)022,500+22,500$0$483.3K0.29%+$483.3K
Palisade Bio, Inc.(PALI)0166,049+166,049$0$390.2K0.23%+$390.2K
Proqr Thrapeutics N VSHS EURO
SHS EURO
157,694167,532+9,838$335.9K$338.4K0.20%+$2.5K
Harmony Biosciences Holdings, Inc.(HRMY)50,0007,500-42,500$1.38M$280.6K0.17%-$1.10M
Aardvark Therapeutics Inc015,882+15,882$0$208.5K0.12%+$208.5K
Neuphoria Therapeutics Inc21,45250,000+28,548$252.9K$194.0K0.12%-$58.9K
Pliant Therapeutics, Inc.(PLRX)0144,914+144,914$0$176.8K0.11%+$176.8K
BeOne Medicines AGADS(ONC)07,500+7,500$0$172.8K0.10%+$172.8K
Foghorn Therapeutics Inc.(FHTX)50,00030,630-19,370$244.5K$165.4K0.10%-$79.1K
Talphera, Inc.(TLPH)0136,923+136,923$0$156.1K0.09%+$156.1K
PureTech Health plcADS(PRTCY)7,3247,442+118$135.5K$123.8K0.07%-$11.7K
Inhibrx Biosciences, Inc.(INBX)01,299+1,299$0$102.6K0.06%+$102.6K
Edesa Biotech, Inc.(EDSA)054,025+54,025$0$76.7K0.05%+$76.7K
Vistagen Therapeutics, Inc.(VTGN)349,789100,000-249,789$1.24M$66.2K0.04%-$1.18M
Alector Inc136,0230-136,023$402.6K$0—-$402.6K
Alkermes plcSHS(ALKS)72,0790-72,079$2.16M$0—-$2.16M
Amylyx Pharmaceuticals, Inc.(AMLX)100,0000-100,000$1.36M$0—-$1.36M
Anaptysbio Inc3,2950-3,295$100.9K$0—-$100.9K
Apogee Therapeutics Inc64,2500-64,250$2.55M$0—-$2.55M
Arcturus Therapeutics Holdings Inc.(ARCT)48,8110-48,811$899.6K$0—-$899.6K
Avidity Biosciences Inc30,0000-30,000$1.31M$0—-$1.31M
Bristol-Myers Squibb Company(BMY)130,0000-130,000$5.86M$0—-$5.86M
Catalyst Pharmaceuticals Inc50,0000-50,000$985.0K$0—-$985.0K
Climb Bio, Inc.(CLYM)136,4880-136,488$274.3K$0—-$274.3K
CytomX Therapeutics, Inc.(CTMX)185,2860-185,286$591.1K$0—-$591.1K
Jazz Pharmaceuticals plcSHS USD(JAZZ)23,1400-23,140$3.05M$0—-$3.05M
Mind Medicine Mindmed Inc105,8910-105,891$1.25M$0—-$1.25M
Moderna, Inc.(MRNA)20,0000-20,000$516.6K$0—-$516.6K
Nektar Therapeutics(NKTR)75,0000-75,000$4.27M$0—-$4.27M
Neurocrine Biosciences, Inc.(NBIX)37,7540-37,754$5.30M$0—-$5.30M
Novo Nordisk A/SADR(NVO)25,0000-25,000$1.39M$0—-$1.39M
Ovid Therapeutics Inc.(OVID)187,7390-187,739$244.1K$0—-$244.1K
PMV Pharmaceuticals, Inc.(PMVP)11,3000-11,300$15.8K$0—-$15.8K
Pyxis Oncology, Inc.(PYXS)150,0000-150,000$333.0K$0—-$333.0K
Relay Therapeutics, Inc.(RLAY)43,6160-43,616$227.7K$0—-$227.7K
Reviva Pharmaceutcls Hldgs I2,506,9210-2,506,921$924.1K$0—-$924.1K
Roivant Sciences Ltd.SHS(ROIV)120,0000-120,000$1.82M$0—-$1.82M
Supernus Pharmaceuticals, Inc.(SUPN)22,3480-22,348$1.07M$0—-$1.07M
Tenaya Therapeutics, Inc.(TNYA)315,5190-315,519$511.1K$0—-$511.1K
Tvardi Therapeutics, Inc.(TVRD)2,1850-2,185$85.1K$0—-$85.1K
Ultragenyx Pharmaceutical Inc.(RARE)9,1890-9,189$276.4K$0—-$276.4K
Page 1 of 1
DIADEMA PARTNERS LP — 13F Holdings — Q4 2025 | TickerTrail